Christopher A. Viehbacher

President and Chief Executive Officer · Biogen

Biotechnology

Christopher A. Viehbacher is Biogen’s president and chief executive officer, following leadership of Sanofi, Gurnet Point Capital and GSK’s North American pharmaceutical business.

Last reviewed: Nov 2, 2026

Christopher A. Viehbacher

President and Chief Executive Officer
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Christopher A. Viehbacher is Biogen’s president and chief executive officer, following leadership of Sanofi, Gurnet Point Capital and GSK’s North American pharmaceutical business.

Career Highlights

  • Became Biogen president, CEO and a director in November 2022.
  • Led Sanofi globally from 2008 to 2014.
  • Was managing partner of Gurnet Point Capital from 2015 to 2022.

Professional Journey

Viehbacher began his career at PricewaterhouseCoopers and qualified as a chartered accountant. He subsequently spent more than 20 years at GlaxoSmithKline, with assignments in Germany, Canada, France and the United States. His later responsibilities included the presidency of GSK’s North American pharmaceutical division.

From 2008 to 2014, he was global chief executive officer of Sanofi. The appointment followed his experience running a large regional pharmaceutical operation and gave him responsibility for the company’s worldwide business.

In 2015, Viehbacher became managing partner of Gurnet Point Capital, the Boston investment firm he co-founded with Ernesto Bertarelli. He remained there until 2022, working with entrepreneurial healthcare companies after his tenure leading an established pharmaceutical group.

Viehbacher joined Biogen as president and CEO in November 2022 and also joined its board. His governance experience includes earlier directorships at Sanofi and GSK and work with companies including Vedanta Biosciences, BEFORE Brands and Crossover Health. He is also a Northeastern University trustee and a member of Stanford Medical School’s board of fellows.

Education

Viehbacher earned a B.A. from Queen’s University in Kingston, Ontario, and qualified as a chartered accountant.